NEST 2025 Highlights -無錫耐思生命科技株式会社

📢 NEST 2025 Highlights
A Year of Steady Progress and Continuous Growth 👍
✔️ Launched multiple new products, expanding our laboratory product portfolio
✔️ Several products obtained Class II medical device certification
✔️ Upgraded and optimized core products to enhance user experience
✔️ Actively participated in industry exhibitions, engaging with customers face to face
✔️ Built a solid foundation for continued growth in 2026
PART 1️⃣ | Innovation — 20+ New Products Launched
01 In 2025, NEST successively launched reusable pen injectors, more cost-effective disposable pen injectors, ready-to-use sterile accessory products, and combination-product assembly equipment, delivering safer, more convenient, and more user-friendly self-injection solutions for the biopharmaceutical industry.

02 NEST expanded its bioprocessing accessory portfolio with large-volume specifications.

03 NEST launched the new T400 Cell Culture Flask.

04 NEST introduced low-binding pipette tips, designed to reduce enzyme or antibody loss, improve experimental accuracy, and minimize sample waste.

05 NEST launched slidable Petri dishes, specifically designed for automated filling systems.
PART 2️⃣ | Compliance — Advancing Within Standards
In 2025, multiple NEST products obtained Class II medical device registrations as well as import medical device approvals in multiple countries. These achievements were officially released through authorized channels, reflecting comprehensive verification of product safety, stability, and regulatory compliance.

PART 3️⃣ | Continuous Iteration in Maturity
In 2025, NEST upgraded and optimized several mature products:
01 Added COA QR codes to product packaging, enhancing overall packaging services.

02 Upgraded GelNest Organoid V3, NEST’s third-generation large-scale model.

03 Added maximum freezing position indicators to NEST centrifuge tubes.

04 Launched narrow-neck versions of NEST round reagent bottles.
PART 4️⃣ | On Site — Engaging with the Industry
Throughout the year, NEST actively participated in 30+ industry exhibitions and professional meetings, connecting face-to-face with partners and customers across different cities and scenarios.

PART 5️⃣ | 2026 — We Are On The Way
In 2026, new product planning and development will continue steadily across pre-filled syringes, general accessories, closed systems, and routine consumables.
With a stronger foundation, NEST is ready to enter a new stage of growth in 2026. 🎉

リストに戻る

前の章：NEST Tube is adopted by WHO, Uganda to test Ebola Vaccines in outbreak 2022-11-24

次の章：ありません